SPOTLIGHT -
EP. 1: CAR T-Cell Therapy in Pediatric ALL
EP. 2: A Conversation on MRD in ALL
EP. 3: Treating Common Toxicities From CAR T Therapy
EP. 4: CAR T-Cell Therapy: Relapsed/Refractory ALL
EP. 5: Adult ALL and Data from ZUMA-3
EP. 6: High-Risk Lymphoma: The ZUMA-1 and SCHOLAR-1 Trials
EP. 7: CAR-T Therapy Treatment Variables
EP. 8: Real-World Data and CAR T Therapy
EP. 9: CAR T Associated Cytokine Release Syndrome
EP. 10: The TRANSCEND-NHL-001 Trial
EP. 11: Expanded Use of CAR T Therapy in Hematologic Malignancies
EP. 12: Next-Generation CAR T Therapy
EP. 13: Anticipation of ZUMA-7 Results
EP. 14: CAR T-Cell Therapy as an Outpatient Treatment Option
Further Understanding of Immune Mechanisms in Tumor Microenvironment Is Key to Advancing Immunotherapy in Solid Tumors
Navigating Systemic Therapy for RCC: Balancing Risk Status and Response
ADCs, Novel Targets Represent Next Wave of Treatment Advances in mCRPC
Precision Medicine in Prostate Cancer Care: Keeping Up With Evolving Guidance for Testing and Decision Making
